St. Luke’s Neurosciences has become the first health system in the region to offer the FDA-approved NeuroPace Responsive Neurostimulation (RNS) System, an advanced treatment for adults with drug-resistant epilepsy.
The first implantation of the RNS System at St. Luke’s University Hospital in Bethlehem was recently performed by stereotactic neurosurgeon Dr. Brice Kessler in collaboration with epileptologist Dr. Brian Hanrahan.
Hospital officials said the procedure marks a significant advancement in personalized treatment for patients whose seizures cannot be controlled with medication alone…